サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1633877

希少疾病用医薬品CDMOの世界市場分析と予測（～2033年）：タイプ、製品、サービス、技術、用途、エンドユーザー、ステージ、プロセス、形態、コンポーネント

Orphan Drugs CDMO Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Stage, Process, Mode, Component

出版日
ページ情報
英文 363 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
希少疾病用医薬品CDMOの世界市場分析と予測（～2033年）：タイプ、製品、サービス、技術、用途、エンドユーザー、ステージ、プロセス、形態、コンポーネント
出版日: 2025年01月13日
発行: Global Insight Services
ページ情報: 英文 363 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の希少疾病用医薬品CDMOの市場規模は、2023年の135億米ドルから2033年には278億米ドルに拡大すると予測され、CAGRは7.4%となる見通しです。

希少疾病用医薬品CDMO市場には、希少疾病の治療薬として開発された医薬品である希少疾病用医薬品に特化した開発・製造受託サービスが含まれます。この市場には、製剤化、スケールアップ、臨床試験生産、商業化支援など、希少疾病用医薬品開発特有の課題や規制要件に対応したソリューションが含まれます。

希少疾病用医薬品CDMOは、希少疾病の有病率の上昇と有利な規制枠組みに牽引され、堅調な拡大を見せています。生物製剤の製造は、先端治療薬と個別化医療に対する需要の増加を背景に、サブセグメントの中でトップの実績を上げています。低分子医薬品の製造は、技術の進歩とコスト効率の高い製造ソリューションに支えられ、2番目に高い実績を上げています。地域別では北米が市場をリードしており、確立された医療インフラ、強力な研究開発能力、政府の支援政策がその要因となっています。欧州は、戦略的提携、技術革新のインセンティブ、希少疾病治療への関心の高まりに後押しされ、2番目に有利な地域となっています。アジア太平洋は、規模は小さいですが、医療へのアクセスの改善、投資の増加、製薬産業の急成長により、勢いを増しています。このダイナミックな市場情勢は、アンメット・メディカル・ニーズに対応し、希少疾病用医薬品開発のイノベーションを促進するCDMOの重要な役割を浮き彫りにしています。

2023年、希少疾病用医薬品CDMO市場は1億5,000万ユニットを記録し、2033年には2億5,000万ユニットに達する見込みです。市場シェアは、生物製剤が45%で最も高く、低分子が30%、遺伝子治療が25%となっています。この成長の原動力となっているのは、個別化医療に対する需要の高まりと希少疾病の有病率の上昇です。同市場の主要企業には、ロンザ・グループ、キャタレント、サーモ・フィッシャー・サイエンティフィックが含まれ、それぞれが確固たる存在感を示しています。ロンザ・グループは高度なバイオ製造技術への投資で特に注目されており、キャタレントは遺伝子治療能力の拡大に注力しています。

競合情勢は戦略的提携や合併によって形成されており、希少疾病用医薬品法や市場情勢規制などの規制枠組みが市場力学に影響を及ぼしています。これらの規制は、市場独占権や税控除などのインセンティブを提供し、技術革新を推進する上で極めて重要です。市場の見通しは依然として楽観的で、生物製剤と遺伝子治療には大きなビジネスチャンスがあります。しかし、高い開発コストや規制上のハードルといった課題は依然として残っています。医薬品開発プロセスにおけるAIと機械学習の統合は、新たな成長展望を切り開くと予想されます。

北米の希少疾病用医薬品CDMO市場は、高度な医療インフラと医薬品研究への多額の投資によって堅調に推移しています。米国はこの地域をリードしており、強力な規制の枠組みと希少疾病に対する多額の資金提供の恩恵を受けています。これがイノベーションを促進し、医薬品開発プロセスを加速させています。次いで、政府の政策が後押しし、バイオテクノロジー産業の存在感が増しているカナダが続きます。

欧州市場の特徴は、協調的な規制環境と希少疾病用医薬品開発への多額の資金援助です。欧州医薬品庁は、市場参入を促進する上で極めて重要な役割を果たしています。ドイツやフランスのような国々は、製薬部門が強く、希少疾病研究に重点を置いているため、際立っています。

アジア太平洋は、医療支出の増加と希少疾病に対する意識の高まりにより、希少疾病用医薬品CDMO市場が急成長しています。中国と日本が主要国であり、政府の主導で研究開発が支援されています。同地域のバイオテクノロジー部門は拡大しており、市場の可能性をさらに高めています。

ラテンアメリカは、ブラジルとメキシコを筆頭に有望な成長を示しています。これらの国々は医療インフラに投資し、グローバル製薬企業とのパートナーシップを育んでいます。これにより、希少疾病用医薬品の開発・製造能力が高まっています。

中東・アフリカは、希少疾病用医薬品CDMO市場で徐々に台頭してきています。サウジアラビアや南アフリカのような国々は医療の進歩に投資しています。これらの国々は、需要の増加や政府のイニシアチブに後押しされ、希少疾病の治療開発をサポートする能力を構築しています。

目次

第1章 希少疾病用医薬品CDMO市場の概要

  • 調査目的
  • 希少疾病用医薬品CDMO市場の定義と調査範囲
  • レポートの制限事項
  • 調査対象年および通貨
  • 調査手法

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 希少疾病用医薬品CDMO市場の展望

  • 希少疾病用医薬品CDMO市場のセグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 4Pモデル
  • ANSOFFマトリックス

第5章 希少疾病用医薬品CDMO市場の戦略

  • 親市場分析
  • 需給分析
  • 消費者の購買意欲
  • ケーススタディ分析
  • 価格分析
  • 規制状況
  • サプライチェーン分析
  • 競合製品分析
  • 最近の動向

第6章 希少疾病用医薬品CDMOの市場規模

  • 希少疾病用医薬品CDMOの市場規模：金額別
  • 希少疾病用医薬品CDMOの市場規模：数量別

第7章 希少疾病用医薬品CDMO市場：タイプ別

  • 市場概要
  • 低分子医薬品
  • 生物製剤
  • 遺伝子治療薬
  • 細胞療法
  • 抗体
  • ペプチド
  • RNAベース
  • ウイルスベクター
  • 非ウイルス性ベクター
  • その他

第8章 希少疾病用医薬品CDMO市場：製品別

  • 市場概要
  • 原薬（API）
  • 最終製剤（FDF）
  • 中間体
  • その他

第9章 希少疾病用医薬品CDMO市場：サービス別

  • 市場概要
  • 製造
  • 製剤開発
  • 分析・品質管理
  • 薬事サポート
  • 臨床試験
  • サプライチェーンマネジメント
  • 包装
  • その他

第10章 希少疾病用医薬品CDMO市場：技術別

  • 市場概要
  • バイオプロセス
  • 凍結乾燥
  • スプレードライ
  • マイクロカプセル化
  • ナノ粒子工学
  • 連続製造
  • その他

第11章 希少疾病用医薬品CDMO市場：用途別

  • 市場概要
  • がん領域
  • 神経
  • 血液学
  • 循環器
  • 代謝疾患
  • 感染症学
  • 遺伝子疾患
  • その他

第12章 希少疾病用医薬品CDMO市場：エンドユーザー別

  • 市場概要
  • 製薬企業
  • バイオテクノロジー企業
  • 研究・学術機関
  • CRO（医薬品開発業務受託機関）
  • その他

第13章 希少疾病用医薬品CDMO市場：ステージ別

  • 市場概要
  • 前臨床
  • フェーズI
  • フェーズII
  • フェーズIII
  • 商品化
  • その他

第14章 希少疾病用医薬品CDMO市場：プロセス別

  • 市場概要
  • 上流
  • 下流
  • 製剤化
  • その他

第15章 希少疾病用医薬品CDMO市場：形態別

  • 市場概要
  • インハウス
  • アウトソーシング
  • その他

第16章 希少疾病用医薬品CDMO市場：コンポーネント別

  • 市場概要
  • 設備
  • 消耗品
  • ソフトウェア
  • その他

第17章 希少疾病用医薬品CDMO市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • オランダ
    • スウェーデン
    • スイス
    • デンマーク
    • フィンランド
    • ロシア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • シンガポール
    • インドネシア
    • 台湾
    • マレーシア
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他中東・アフリカ

第18章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業のポジショニング
  • 競合リーダーシップマッピング
  • ベンダーベンチマーキング
  • 開発戦略のベンチマーキング

第19章 企業プロファイル

  • Lonza
  • Catalent
  • Samsung Biologics
  • WuXi Biologics
  • Boehringer Ingelheim BioXcellence
  • Fujifilm Diosynth Biotechnologies
  • AGC Biologics
  • Thermo Fisher Scientific
  • Recipharm
  • Piramal Pharma Solutions
  • Almac Group
  • Biocon
  • CordenPharma
  • Patheon
  • Ajinomoto Bio-Pharma Services
  • Abzena
  • Rentschler Biopharma
  • KBI Biopharma
  • Cambrex
  • Siegfried
目次
Product Code: GIS26276

The orphan drugs CDMO market is anticipated to expand from $13.5 billion in 2023 to $27.8 billion by 2033, reflecting a CAGR of 7.4%.

The Orphan Drugs CDMO market encompasses the specialized contract development and manufacturing services dedicated to orphan drugs, which are pharmaceutical agents developed to treat rare diseases. This market involves tailored solutions in drug formulation, scale-up, clinical trial production, and commercialization support, addressing the unique challenges and regulatory requirements of orphan drug development, thereby facilitating the availability of treatments for underserved patient populations.

The Orphan Drugs CDMO Market is witnessing robust expansion, driven by the rising prevalence of rare diseases and favorable regulatory frameworks. Biologics manufacturing emerges as the top-performing sub-segment, attributed to the increasing demand for advanced therapeutics and personalized medicine. Small molecule production follows as the second-highest performing sub-segment, supported by technological advancements and cost-effective manufacturing solutions. Regionally, North America leads the market, benefiting from well-established healthcare infrastructure, strong R&D capabilities, and supportive government policies. Europe stands as the second most lucrative region, propelled by strategic collaborations, innovation incentives, and a growing focus on rare disease treatment. The Asia-Pacific region, though smaller, is gaining momentum, driven by improving healthcare access, increasing investments, and a burgeoning pharmaceutical industry. This dynamic market landscape underscores the critical role of CDMOs in addressing unmet medical needs and fostering innovation in orphan drug development.

In 2023, the Orphan Drugs CDMO Market recorded a volume of 150 million units, with expectations to reach 250 million units by 2033. The biologics segment commands the largest market share at 45%, followed by small molecules at 30%, and gene therapies at 25%. This growth is driven by increasing demand for personalized medicine and the rising prevalence of rare diseases. Key players in the market include Lonza Group, Catalent, and Thermo Fisher Scientific, each maintaining a robust presence. Lonza Group is particularly noted for its investment in advanced biomanufacturing technologies, while Catalent focuses on expanding its gene therapy capabilities.

The competitive landscape is shaped by strategic collaborations and mergers, with regulatory frameworks such as the Orphan Drug Act and EMA Orphan Regulation influencing market dynamics. These regulations offer incentives, including market exclusivity and tax credits, which are crucial for driving innovation. The market outlook remains optimistic, with significant opportunities in biologics and gene therapies. However, challenges such as high development costs and regulatory hurdles persist. The integration of AI and machine learning in drug development processes is anticipated to unlock new growth prospects.

The North American orphan drugs CDMO market is robust, driven by advanced healthcare infrastructure and significant investments in pharmaceutical research. The United States leads this region, benefiting from a strong regulatory framework and substantial funding for rare diseases. This fosters innovation and accelerates drug development processes. Canada follows, with supportive government policies and growing biotech industry presence.

Europe's market is characterized by a collaborative regulatory environment and substantial funding for orphan drug development. The European Medicines Agency plays a pivotal role in facilitating market access. Countries like Germany and France are prominent due to their strong pharmaceutical sectors and emphasis on rare disease research.

Asia Pacific is experiencing rapid growth in the orphan drugs CDMO market, driven by increasing healthcare expenditure and rising awareness of rare diseases. China and Japan are key players, with government initiatives supporting research and development. The region's expanding biotechnology sector further enhances its market potential.

Latin America shows promising growth, with Brazil and Mexico leading the charge. These countries are investing in healthcare infrastructure and fostering partnerships with global pharmaceutical companies. This enhances their capacity to develop and manufacture orphan drugs.

The Middle East and Africa region is gradually emerging in the orphan drugs CDMO market. Countries like Saudi Arabia and South Africa are investing in healthcare advancements. They are building capabilities to support the development of treatments for rare diseases, driven by increasing demand and government initiatives.

Key Companies

Lonza, Catalent, Samsung Biologics, Wu Xi Biologics, Boehringer Ingelheim Bio Xcellence, Fujifilm Diosynth Biotechnologies, AGC Biologics, Thermo Fisher Scientific, Recipharm, Piramal Pharma Solutions, Almac Group, Biocon, Corden Pharma, Patheon, Ajinomoto Bio- Pharma Services, Abzena, Rentschler Biopharma, KBI Biopharma, Cambrex, Siegfried

Sources

U.S. Food and Drug Administration - Orphan Products Clinical Trials Grants Program, European Medicines Agency - Orphan Medicines, National Institutes of Health - Office of Rare Diseases Research, World Health Organization - Rare Diseases, International Rare Diseases Research Consortium, Orphanet - Portal for Rare Diseases and Orphan Drugs, National Organization for Rare Disorders, Genetic and Rare Diseases Information Center, European Organisation for Rare Diseases (EURORDIS), Global Genes, International Conference on Rare Diseases & Orphan Drugs, World Orphan Drug Congress, Rare Disease Day (EURORDIS Event), U.S. National Library of Medicine - PubMed, National Center for Advancing Translational Sciences, European Commission - Health and Food Safety, Biotechnology Innovation Organization, U.S. Department of Health & Human Services - Health Resources and Services Administration, International Society for Pharmaceutical Engineering, American Society of Gene & Cell Therapy

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Orphan Drugs CDMO Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Orphan Drugs CDMO Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Stage
  • 2.10 Key Highlights of the Market, by Process
  • 2.11 Key Highlights of the Market, by Mode
  • 2.12 Key Highlights of the Market, by Component
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Stage
  • 3.9 Market Attractiveness Analysis, by Process
  • 3.10 Market Attractiveness Analysis, by Mode
  • 3.11 Market Attractiveness Analysis, by Component
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Orphan Drugs CDMO Market Outlook

  • 4.1 Orphan Drugs CDMO Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Orphan Drugs CDMO Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Orphan Drugs CDMO Market Size

  • 6.1 Orphan Drugs CDMO Market Size, by Value
  • 6.2 Orphan Drugs CDMO Market Size, by Volume

7: Orphan Drugs CDMO Market, by Type

  • 7.1 Market Overview
  • 7.2 Small Molecule
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Biologics
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Gene Therapy
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Cell Therapy
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Antibody
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Peptide
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 RNA-based
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Viral Vectors
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Non-Viral Vectors
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region
  • 7.11 Others
    • 7.11.1 Key Market Trends & Opportunity Analysis
    • 7.11.2 Market Size and Forecast, by Region

8: Orphan Drugs CDMO Market, by Product

  • 8.1 Market Overview
  • 8.2 Active Pharmaceutical Ingredients (API)
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Finished Dosage Forms (FDF)
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Intermediates
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: Orphan Drugs CDMO Market, by Services

  • 9.1 Market Overview
  • 9.2 Manufacturing
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Formulation Development
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Analytical and Quality Control
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Regulatory Support
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Clinical Trials
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Supply Chain Management
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Packaging
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Others
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region

10: Orphan Drugs CDMO Market, by Technology

  • 10.1 Market Overview
  • 10.2 Bioprocessing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Lyophilization
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Spray Drying
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Microencapsulation
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Nanoparticle Engineering
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Continuous Manufacturing
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Orphan Drugs CDMO Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Neurology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Hematology
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Cardiology
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Metabolic Disorders
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Infectious Diseases
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Genetic Disorders
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Others
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region

12: Orphan Drugs CDMO Market, by End User

  • 12.1 Market Overview
  • 12.2 Pharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology Firms
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research and Academic Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Contract Research Organizations (CROs)
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Orphan Drugs CDMO Market, by Stage

  • 13.1 Market Overview
  • 13.2 Preclinical
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Phase I
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Phase II
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Phase III
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Commercial
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Others
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region

14: Orphan Drugs CDMO Market, by Process

  • 14.1 Market Overview
  • 14.2 Upstream
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Downstream
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Formulation
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Orphan Drugs CDMO Market, by Mode

  • 15.1 Market Overview
  • 15.2 In-house
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Outsourced
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Orphan Drugs CDMO Market, by Component

  • 16.1 Market Overview
  • 16.2 Equipment
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Consumables
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Software
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Orphan Drugs CDMO Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Stage
    • 17.2.9 North America Market Size and Forecast, by Process
    • 17.2.10 North America Market Size and Forecast, by Mode
    • 17.2.11 North America Market Size and Forecast, by Component
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Stage
      • 17.2.9.8 United States Market Size and Forecast, by Process
      • 17.2.9.9 United States Market Size and Forecast, by Mode
      • 17.2.9.10 United States Market Size and Forecast, by Component
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Stage
      • 17.2.10.8 Canada Market Size and Forecast, by Process
      • 17.2.10.9 Canada Market Size and Forecast, by Mode
      • 17.2.10.10 Canada Market Size and Forecast, by Component
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Stage
    • 17.3.9 Europe Market Size and Forecast, by Process
    • 17.3.10 Europe Market Size and Forecast, by Mode
    • 17.3.11 Europe Market Size and Forecast, by Component
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Stage
      • 17.3.10.8 Germany Market Size and Forecast, by Process
      • 17.3.10.9 Germany Market Size and Forecast, by Mode
      • 17.3.10.10 Germany Market Size and Forecast, by Component
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Stage
      • 17.3.11.8 France Market Size and Forecast, by Process
      • 17.3.11.9 France Market Size and Forecast, by Mode
      • 17.3.11.10 France Market Size and Forecast, by Component
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Stage
      • 17.3.12.8 Spain Market Size and Forecast, by Process
      • 17.3.12.9 Spain Market Size and Forecast, by Mode
      • 17.3.12.10 Spain Market Size and Forecast, by Component
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Stage
      • 17.3.13.8 Italy Market Size and Forecast, by Process
      • 17.3.13.9 Italy Market Size and Forecast, by Mode
      • 17.3.13.10 Italy Market Size and Forecast, by Component
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.8 Netherlands Market Size and Forecast, by Process
      • 17.3.14.9 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.10 Netherlands Market Size and Forecast, by Component
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Stage
      • 17.3.15.8 Sweden Market Size and Forecast, by Process
      • 17.3.15.9 Sweden Market Size and Forecast, by Mode
      • 17.3.15.10 Sweden Market Size and Forecast, by Component
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.8 Switzerland Market Size and Forecast, by Process
      • 17.3.16.9 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.10 Switzerland Market Size and Forecast, by Component
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Stage
      • 17.3.17.8 Denmark Market Size and Forecast, by Process
      • 17.3.17.9 Denmark Market Size and Forecast, by Mode
      • 17.3.17.10 Denmark Market Size and Forecast, by Component
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Stage
      • 17.3.18.8 Finland Market Size and Forecast, by Process
      • 17.3.18.9 Finland Market Size and Forecast, by Mode
      • 17.3.18.10 Finland Market Size and Forecast, by Component
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Stage
      • 17.3.19.8 Russia Market Size and Forecast, by Process
      • 17.3.19.9 Russia Market Size and Forecast, by Mode
      • 17.3.19.10 Russia Market Size and Forecast, by Component
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Stage
      • 17.4.9.8 China Market Size and Forecast, by Process
      • 17.4.9.9 China Market Size and Forecast, by Mode
      • 17.4.9.10 China Market Size and Forecast, by Component
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Stage
      • 17.4.10.8 India Market Size and Forecast, by Process
      • 17.4.10.9 India Market Size and Forecast, by Mode
      • 17.4.10.10 India Market Size and Forecast, by Component
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Stage
      • 17.4.11.8 Japan Market Size and Forecast, by Process
      • 17.4.11.9 Japan Market Size and Forecast, by Mode
      • 17.4.11.10 Japan Market Size and Forecast, by Component
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Stage
      • 17.4.12.8 South Korea Market Size and Forecast, by Process
      • 17.4.12.9 South Korea Market Size and Forecast, by Mode
      • 17.4.12.10 South Korea Market Size and Forecast, by Component
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Stage
      • 17.4.13.8 Australia Market Size and Forecast, by Process
      • 17.4.13.9 Australia Market Size and Forecast, by Mode
      • 17.4.13.10 Australia Market Size and Forecast, by Component
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Stage
      • 17.4.14.8 Singapore Market Size and Forecast, by Process
      • 17.4.14.9 Singapore Market Size and Forecast, by Mode
      • 17.4.14.10 Singapore Market Size and Forecast, by Component
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.8 Indonesia Market Size and Forecast, by Process
      • 17.4.15.9 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.10 Indonesia Market Size and Forecast, by Component
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.8 Taiwan Market Size and Forecast, by Process
      • 17.4.16.9 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.10 Taiwan Market Size and Forecast, by Component
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.8 Malaysia Market Size and Forecast, by Process
      • 17.4.17.9 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.10 Malaysia Market Size and Forecast, by Component
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Stage
    • 17.5.9 Latin America Market Size and Forecast, by Process
    • 17.5.10 Latin America Market Size and Forecast, by Mode
    • 17.5.11 Latin America Market Size and Forecast, by Component
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Stage
      • 17.5.9.8 Brazil Market Size and Forecast, by Process
      • 17.5.9.9 Brazil Market Size and Forecast, by Mode
      • 17.5.9.10 Brazil Market Size and Forecast, by Component
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Stage
      • 17.5.10.8 Mexico Market Size and Forecast, by Process
      • 17.5.10.9 Mexico Market Size and Forecast, by Mode
      • 17.5.10.10 Mexico Market Size and Forecast, by Component
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Stage
      • 17.5.11.8 Argentina Market Size and Forecast, by Process
      • 17.5.11.9 Argentina Market Size and Forecast, by Mode
      • 17.5.11.10 Argentina Market Size and Forecast, by Component
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Stage
      • 17.6.10.8 UAE Market Size and Forecast, by Process
      • 17.6.10.9 UAE Market Size and Forecast, by Mode
      • 17.6.10.10 UAE Market Size and Forecast, by Component
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Stage
      • 17.6.11.8 South Africa Market Size and Forecast, by Process
      • 17.6.11.9 South Africa Market Size and Forecast, by Mode
      • 17.6.11.10 South Africa Market Size and Forecast, by Component
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Lonza
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Catalent
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Samsung Biologics
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 WuXi Biologics
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Boehringer Ingelheim BioXcellence
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Fujifilm Diosynth Biotechnologies
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 AGC Biologics
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Thermo Fisher Scientific
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Recipharm
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Piramal Pharma Solutions
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Almac Group
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Biocon
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 CordenPharma
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Patheon
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Ajinomoto Bio-Pharma Services
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Abzena
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Rentschler Biopharma
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 KBI Biopharma
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Cambrex
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Siegfried
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis